GO:0036457 keratohyalin granule: Components, Assembly

Keratohyalin granules (GO:0036457) are cytoplasmic, non-membrane-bound structures found in keratinocytes, the predominant cell type of the epidermis and other stratified epithelia. These granules are classically observed in the granular layer of the epidermis and are associated with keratin intermediate filaments, to which they are partially crosslinked via the cell envelope. Their presence is a hallmark of terminal differentiation in keratinocytes, and they serve as a reservoir for proteins that are essential for skin barrier formation. The study of keratohyalin granules is important for understanding normal skin biology and diseases such as atopic dermatitis and ichthyosis vulgaris, where granule abnormalities are often observed. Historically, keratohyalin granules were identified by electron microscopy as electron-dense, irregularly shaped deposits in the cytoplasm of granular keratinocytes. Subsequent biochemical studies revealed that they are composed largely of profilaggrin, a large polyprotein that is proteolytically processed into filaggrin monomers during terminal differentiation. Filaggrin then aggregates keratin filaments and is later degraded into free amino acids that contribute to the natural moisturizing factor of the skin. In addition to filaggrin, keratohyalin granules contain other proteins such as trichohyalin, and in some epithelia, hybrid granules containing both keratohyalin and trichohyalin are formed. The composition and maturation of these granules are tightly regulated, and defects in this process can lead to impaired skin barrier function and inflammatory skin diseases. Recent research has begun to uncover the molecular machinery that controls keratohyalin granule formation and maturation. For example, the small GTPase RAB25 has been shown to coordinate the maturation of filaggrin-containing keratohyalin granules, and its expression levels correlate with atopic dermatitis severity. Furthermore, type XVIII collagen, a component of the extracellular matrix, modulates keratohyalin granule formation and keratinization in oral mucosa, suggesting that the extracellular environment influences granule assembly. These findings highlight the importance of keratohyalin granules as dynamic organelles that integrate multiple cellular signals to ensure proper skin barrier function. Understanding their biology at the molecular level is essential for developing targeted therapies for skin disorders characterized by barrier dysfunction.

According to the Gene Ontology, keratohyalin granule (GO:0036457) is a cytoplasmic, non-membrane-bound granule found in at least keratinocytes. It is associated with keratin intermediate filaments and is partially crosslinked to the cell envelope. This definition captures the structural and functional features of these granules as specialized compartments that contribute to the mechanical and barrier properties of the epidermis.

Keratohyalin granules are critical for the terminal differentiation of keratinocytes and the formation of a functional skin barrier. They serve as the site of profilaggrin processing and filaggrin storage, which are essential for aggregating keratin filaments and maintaining epidermal integrity. Defects in keratohyalin granule formation or composition are associated with common skin disorders such as atopic dermatitis and ichthyosis vulgaris, making them a focus of dermatological research. Additionally, understanding how these granules assemble and mature can provide insights into general mechanisms of protein aggregation and organelle biogenesis in non-membrane-bound compartments.

The following genes and proteins are key components or regulators of keratohyalin granules, based on published literature.

The formation and maturation of keratohyalin granules are regulated at multiple levels. Transcriptional control of FLG and other granule component genes is mediated by transcription factors such as KLF4 and AP1, which respond to differentiation signals. Post-translational processing of profilaggrin is calcium-dependent and involves proteases like calpain and caspase-14. The small GTPase RAB25 plays a critical role in granule maturation, and its expression is modulated in inflammatory skin conditions. Additionally, extracellular matrix components such as type XVIII collagen can influence granule formation in oral mucosa, suggesting that cell-matrix interactions contribute to regulation. Cytokines such as IL-4 and IL-13, which are elevated in atopic dermatitis, downregulate filaggrin expression and may impair granule integrity.

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by skin barrier dysfunction. Loss-of-function mutations in FLG, which encodes the major keratohyalin granule protein profilaggrin, are a major risk factor for AD. Recent studies have shown that RAB25, a regulator of keratohyalin granule maturation, affects AD severity, and its expression is reduced in lesional skin. The Th2 cytokines IL-4 and IL-13, which are elevated in AD, downregulate filaggrin expression and may contribute to abnormal granule formation. These findings highlight the importance of keratohyalin granules in AD pathogenesis and suggest that targeting granule maturation could be a therapeutic strategy.

Ichthyosis vulgaris (IV) is a common inherited skin disorder characterized by dry, scaly skin. It is most often caused by loss-of-function mutations in FLG, leading to reduced or absent profilaggrin/filaggrin in keratohyalin granules. Histologically, IV skin shows absent or reduced keratohyalin granules in the granular layer, which is a diagnostic hallmark. The absence of filaggrin leads to impaired keratin aggregation and defective skin barrier, resulting in the clinical features of IV. Understanding the role of keratohyalin granules in IV has been instrumental in elucidating the molecular basis of skin barrier function.

Keratohyalin granules are also present in oral mucosa, where they contribute to keratinization. Type XVIII collagen, encoded by COL18A1, has been shown to modulate keratohyalin granule formation and keratinization in oral mucosa. Abnormalities in this process may be associated with oral mucosal disorders, although the exact clinical implications are still under investigation. This highlights the broader relevance of keratohyalin granules beyond the epidermis.

Keratohyalin granules are traditionally visualized using histological stains such as hematoxylin and eosin (H&E), which reveal basophilic granules in the granular layer of the epidermis. Electron microscopy provides ultrastructural details, showing electron-dense, non-membrane-bound granules associated with keratin filaments. Immunofluorescence with antibodies against filaggrin, trichohyalin, or keratin can specifically label granule components and assess their distribution. These methods are essential for basic characterization and for evaluating the effects of genetic manipulations.

CRISPR-Cas9 genome editing enables the creation of knockout, point-mutation, and knock-in models to study gene function in keratohyalin granule biology. For example, FLG knockout keratinocytes have been used to demonstrate the requirement of profilaggrin for granule formation. Overexpression studies can test sufficiency, while tagged knock-in allows for protein localization and interaction studies. These approaches are complemented by RNA interference (RNAi) for transient knockdown.

Proteomic analysis of isolated keratohyalin granules or keratinocyte lysates can identify novel components and post-translational modifications. Immunoprecipitation of profilaggrin or filaggrin followed by mass spectrometry can reveal interacting proteins. Western blotting is used to assess profilaggrin processing and filaggrin expression levels. These techniques help elucidate the molecular composition and dynamics of keratohyalin granules.

Skin barrier function can be assessed using transepidermal water loss (TEWL) measurements in mouse models or 3D skin equivalents. Permeability assays using dyes such as toluidine blue can evaluate barrier defects in histological sections. These functional assays are critical for linking keratohyalin granule abnormalities to physiological outcomes.

Researchers studying keratohyalin granule-related genes often need to determine whether a candidate gene is causally involved in granule formation, maturation, or function. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types such as keratinocytes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.

Keratohyalin granules (GO:0036457) are essential cytoplasmic structures in keratinocytes that play a central role in skin barrier formation through the processing and storage of profilaggrin/filaggrin. Their assembly and maturation are regulated by a network of genes including FLG, RAB25, and COL18A1, and defects in these processes are linked to common skin diseases such as atopic dermatitis and ichthyosis vulgaris. Continued research using advanced genetic and imaging tools will further elucidate the molecular mechanisms governing keratohyalin granule biology and may lead to new therapeutic strategies for skin disorders.